Table 2 Summary for clinical data of different surgical treatment modalities
Treatment(group number) | Age of patients median(range) | Gender of patients | Stage of disease | Median survival months(SE)(CI) | |||||
|---|---|---|---|---|---|---|---|---|---|
Male | Female | Total | III | IVa | IVb | Total | |||
Surgery alone(1) | 69(28–89) | 19(70%) | 8(30%) | 27 | 15(56%) | 10(37%) | 2(7%) | 27 | 18(3.894)(10.367–25.633) |
Surgery + radiotherapy(2) | 63(38–88) | 8(33%) | 16(67%) | 24 | 13(54%) | 10(42%) | 1(4%) | 24 | 32(8.124)(16.077–47.923) |
Surgery + radiotherapy + chemotherapy(3) | 65(45–79) | 10(56%) | 8(44%) | 18 | 9(50%) | 7(39%) | 2(11%) | 18 | 42(14.749)(13.092–70.908) |
P value(group1 vs. group2) | 0.152 | 0.012 | 1.000 | 0.012 | |||||
P value(group1 vs. group3) | 0.310 | 0.354 | 1.000 | 0.002 | |||||
P value(group2 vs. group3) | 0.712 | 0.211 | 0.791 | 0.601 | |||||